Amgen Stock Surges To 10-Month High, Up 5% On An Unexpected UpgradeInvestors Business Daily • 10/11/23
Amgen's cancer-drug pipeline looks promising despite FDA setback, analysts sayMarket Watch • 10/11/23
Amgen to continue to seek full approval of Lumakras cancer drug after FDA panel votes against itMarket Watch • 10/06/23
Neumora Therapeutics stock surges as Amgen confirmed as major holder of the novel depression drug developerProactive Investors • 09/27/23
Amgen discloses more than $400 million stake in recent IPO Neumora TherapeuticsMarket Watch • 09/27/23
Trilliant Health's 2023 Trends Shaping the Health Economy Report Offers Data-Driven Insight Into 10 Secular Trends That Will Define the U.S. Healthcare SystemBusiness Wire • 09/27/23
Stock Market Correction Picks Up Steam; Stocks To Watch Include Amgen, Arch ResourcesInvestors Business Daily • 09/26/23
Dow Jones Biotech Giant Amgen, Meta Stock, Eye Buy Points In Stock Market CorrectionInvestors Business Daily • 09/25/23